Nasdaq - Delayed Quote USD

Fidelity Disruptive Medicine (FMEDX)

11.28 -0.02 (-0.18%)
At close: January 23 at 8:01 PM EST

Fund Summary

Normally the fund invests at least 80% of assets in securities of disruptive medicine companies. Normally it invests primarily in equity securities. Companies within the disruptive medicine theme include but are not limited to those companies that, in the Adviser's opinion, are engaged in robotic surgery, gene therapy, genomics, rare diseases, medical devices and equipment, immunotherapy, technology-based health care platforms, and consumer wellness. The fund is non-diversified.

Fidelity Disruptive Medicine

Boston, MA 02109
82 Devonshire Street

Fund Overview

Category Health
Fund Family Fidelity Investments
Net Assets 43.22M
YTD Return 4.82%
Yield 0.00%
Morningstar Rating
Inception Date Apr 16, 2020

Fund Operations

Last Dividend --
Last Cap Gain -22.00
Holdings Turnover 47.00%
Average for Category --

Fees & Expenses

Expense FMEDX Category Average
Annual Report Expense Ratio (net) 1.00% 1.03%
Prospectus Net Expense Ratio 1.00% --
Prospectus Gross Expense Ratio 1.00% --
Max 12b1 Fee -- --
Max Front End Sales Load -- 5.37%
Max Deferred Sales Load -- 1.19%
3 Yr Expense Projection 0 --
5 Yr Expense Projection 0 --
10 Yr Expense Projection 0 --

Management Information

Charles W Hebard, Lead Manager since April 16, 2020
Charlie Hebard is co-manager of each fund, which he has managed since April 2020. He also manages other funds. Since joining Fidelity Investments in 1999, Mr. Hebard has worked as a managing director of research and portfolio manager. Prior to joining Fidelity, Hebard was an assistant vice president for CiticorpSecurities Inc. in the Global Media and Communications division, from 1996 to 1997.

Morningstar Style Box

Yahoo partners with Morningstar a leading market research and investment data group to help investors rate and compare funds on Yahoo Finance. The Morningstar Category is shown next to the Morningstar Style Box which identifies a fund's investment focus, based on the underlying securities in the fund. MORNING_STAR_STYLE_BOX

Morningstar Category

While the investment objective stated in a fund's prospectus may or may not reflect how the fund actually invests, the Morningstar category is assigned based on the underlying securities in each portfolio. Morningstar categories help investors and investment professionals make meaningful comparisons between funds. The categories make it easier to build well-diversified portfolios, assess potential risk, and identify top-performing funds. We place funds in a given category based on their portfolio statistics and compositions over the past three years. If the fund is new and has no portfolio history, we estimate where it will fall before giving it a more permanent category assignment. When necessary, we may change a category assignment based on recent changes to the portfolio.

Related Tickers